Khaled Mahmoud Abd Elaziz

Khaled Mahmoud Abd Elaziz

Auto-generated profile, based on publicly available information

Khaled Mahmoud Abd Elaziz

Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in The Lancet
Verified
Journal Article
Closed access
RRReda Mr Ramzy
Reda Mr Ramzy
MSMaged El Setouhy
Maged El Setouhy
HHHanan Helmy
Hanan Helmy
EAEhab S Ahmed
Ehab S Ahmed
KEKhaled M Abd Elaziz
Khaled M Abd Elaziz
GWGary J Weil
Gary J Weil

1 December 2007 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
MEMaged El-Setouhy
Maged El-Setouhy
KEKhaled M. Abd Elaziz
Khaled M. Abd Elaziz
HHHanan Helmy
Hanan Helmy
HFHoda A. Farid
Hoda A. Farid
HKHussein A. Kamal
Hussein A. Kamal
GWGary J. Weil
Gary J. Weil
We studied effects of compliance on the impact of mass drug administration (MDA) with diethylcarbamazine and albendazole for lymphatic filariasis (LF) in an Egyptian village. Baseline microfilaremia (mf) and filarial antigenemia rates were 11.5% and 19.0%, respectively. The MDA compliance rates were excellent (> 85%). However, individual compliance was highly variable; 7.4% of those surveyed after five rounds of MDA denied having ever taken the medications and 52.4% reported that they had taken all five doses. The mf and antigenemia rates were 0.2% and 2.7% in those who reported five doses of MDA and 8.3% and 13.8% in those who reported zero doses. There was no significant difference in residual infection rates among those who had taken two or more doses. These results underscore the importance of compliance for LF elimination programs based on MDA and suggest that two ingested doses of MDA are as effective as five doses for reducing filariasis infection rates.

1 March 2017 in Acta Tropica
Verified
Journal Article
Closed access
AHAyat A. Haggag
Ayat A. Haggag
ARAmal Rabiee
Amal Rabiee
KEKhaled M. Abd Elaziz
Khaled M. Abd Elaziz
AGAlbis Francesco Gabrielli
Albis Francesco Gabrielli
RHRehab Abdel Hay
Rehab Abdel Hay
RRReda M.R. Ramzy
Reda M.R. Ramzy

6 March 2019 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
AHAyat A. Haggag
Ayat A. Haggag
ARAmal Rabiee
Amal Rabiee
KEKhaled M. Abd Elaziz
Khaled M. Abd Elaziz
CCCarl H. Campbell
Carl H. Campbell
DCDaniel G. Colley
Daniel G. Colley
RRReda M. R. Ramzy
Reda M. R. Ramzy
Forty-five Schistosoma mansoni egg–negative/circulating cathodic antigen (CCA) low (Trace-1+) positive children in areas of very low prevalence were followed up daily for 30 days. Stool and urine specimens were collected and examined each day from each child. At the midpoint of the study, three egg-positive control persons with light intensity infection were included in the protocol. Stool samples were examined by the Kato–Katz (four slides/stool sample) technique and all S. mansoni egg–negative stools were further tested by the “miracidia hatching test” (MHT). Urine samples were examined by the point-of-care CCA assay (POC-CCA). Over 30 days, only one of 1,338 consecutive stool samples from study subjects was S. mansoni egg and MHT positive (0.07%). Egg counts fluctuated daily in stools from positive controls and S. mansoni miracidia were detected in all but two samples by the MHT. Point-of-care–circulating cathodic antigen bands were scored from G1 to G10 and then translated to standard Trace, 1+, 2+, 3+ banding patterns. In two districts, the POC-CCA assays were Trace or 1+ for both the study children and the positive controls. In the third district, the POC-CCA assays were Trace or 1+ for the study children and 1+ or 2+ for the positive control. We conclude that in areas with extremely low prevalence S. mansoni egg–negative and CCA-Trace or 1+ children are unlikely to pose substantial risks to continued transmission of schistosomiasis. In this setting, POC-CCA Trace or 1+ readings are likely to be false positives or perhaps represent low-level single-sex schistosome infections.

24 November 2004 in Hepatology
Verified
Journal Article
Open access
PDF file
MSMichaël Schwarzinger
Michaël Schwarzinger
SDSahar Dewedar
Sahar Dewedar
CRClaire Rekacewicz
Claire Rekacewicz
KEKhaled Mahmoud Abd Elaziz
Khaled Mahmoud Abd Elaziz
AFArnaud Fontanet
Arnaud Fontanet
MMMostafa Kamal Mohamed
Mostafa Kamal Mohamed
Previous Western studies showed a consistent and marked reduction in health–related quality of life (HRQOL) in patients chronically infected with hepatitis C virus (HCV). However, these studies were conducted on patients whose knowledge of their serological status may have affected their HRQOL. This HRQOL survey conducted in the Egyptian rural population provides a unique opportunity to clarify this issue among a population whose serological status is unknown. HRQOL was assessed by an Arabic translation of the Short–Form 12, and a visual analog scale of the relative severity of one's health status. HCV chronic infection was defined by positive tests for anti–HCV antibody and HCV–RNA. HRQOL was compared according to HCV chronic infection status in linear mixed models adjusted for potential confounding factors, such as age, sex, education, and health care-related risk factors, and adjusted for interviewer as a random effect. One hundred forty–six Egyptians chronically infected with HCV had similar Short–Form 12 and visual analog scale scores, compared with 1,140 uninfected controls from the same rural community. In individuals chronically infected with HCV, serum aminotransferase levels did not correlate with HRQOL. In conclusion , this study did not find a significant reduction of HRQOL in patients chronically infected with HCV compared with uninfected, contemporaneous controls. This may be explained in part by a lower morbidity amongst patients chronically infected with HCV in rural Egypt and a higher morbidity amongst uninfected controls as compared with those of Western studies, as well as a lack of awareness of hepatitis C serological status. (Hepatology 2004;40:1434-1441.)